GG 637 GG 637 (Lansoprazole delayed release 15 mg)
Pill imprint GG 637 GG 637 has been identified as Lansoprazole delayed release 15 mg.
Lansoprazole is used in the treatment of barrett's esophagus; erosive esophagitis; gerd; helicobacter pylori infection; gastritis/duodenitis (and more), and belongs to the drug class proton pump inhibitors. There is no proven risk in humans during pregnancy. Lansoprazole 15 mg is not a controlled substance under the Controlled Substance Act (CSA).
- GG 637 GG 637
- 15 mg
- Rx and/or OTC
- Drug Class:
- Proton pump inhibitors
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Sandoz Pharmaceuticals Inc
- National Drug Code (NDC):
- Inactive Ingredients:
methacrylic acid - ethyl acrylate copolymer (1:1) type a
polyethylene glycol 400
FD&C Blue No. 2
ferric oxide yellow
More about lansoprazole
- Lansoprazole delayed-release capsules
- Lansoprazole orally disintegrating tablets
- Lansoprazole powder packet
- Lansoprazole (Advanced Reading)
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.